Gross Profit for DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current gross profit (TTM) is $2.80B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DXCM
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$2.80B
YoY change
+14.9%
5Y CAGR
+17.0%
Peak year (2025)
$2.80B
Cumulative gross profit
$15.48B
Gross Profit history chart for DexCom (DXCM) from 2000 to 2025
Gross Profit history table for DexCom (DXCM) from 2000 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $2.80B | +14.9% | ||
| 2024 | $2.44B | +6.5% | ||
| 2023 | $2.29B | +21.5% | ||
| 2022 | $1.88B | +12.1% | ||
| 2021 | $1.68B | +31.3% | ||
| 2020 | $1.28B | +37.4% | ||
| 2019 | $931.50M | +40.3% | ||
| 2018 | $663.90M | +34.9% | ||
| 2017 | $492.10M | +30.0% | ||
| 2016 | $378.40M | +35.9% | ||
| 2015 | $278.40M | +57.9% | ||
| 2014 | $176.30M | +76.1% | ||
| 2013 | $100.10M | +114.8% | ||
| 2012 | $46.60M | +30.0% | ||
| 2011 | $35.84M | +94.4% | ||
| 2010 | $18.44M | +403.8% | ||
| 2009 | $3.66M | -166.2% | ||
| 2008 | -$5.53M | -31.8% | ||
| 2007 | -$8.11M | -7.7% | ||
| 2006 | -$8.79M | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — |
Gross Profit values are taken from DexCom's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual gross profit for DexCom (DXCM) came in at $2.80B – grew 14.9% year-over-year.
DexCom gross profit compound annual growth for the 2020–2025 (5 years) window is +17.0%, sustaining 19 straight years of year-over-year growth.
The dataset's maximum gross profit sits at $2.80B (2025); the minimum reading of -$8.79M dates to 2006.
DexCom (DXCM) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.
DexCom Gross Profit by Year
DexCom Gross Profit 2025: $2.80B
DexCom gross profit in 2025 was $2.80B, grew 14.9% from 2024. This figure represents the highest annual value in the available history.
DexCom Gross Profit 2024: $2.44B
DexCom gross profit in 2024 was $2.44B, grew 6.5% from 2023.
DexCom Gross Profit 2023: $2.29B
DexCom gross profit in 2023 was $2.29B, grew 21.5% from 2022.
DexCom Gross Profit 2022: $1.88B
DexCom gross profit in 2022 was $1.88B, grew 12.1% from 2021.
DexCom Gross Profit 2021: $1.68B
DexCom gross profit in 2021 was $1.68B.
See more financial history for DexCom (DXCM).
Sector peers — Gross Profit
Companies in the same sector as DexCom, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is DexCom's gross profit?
- Latest reported gross profit for DexCom (DXCM) is $2.80B (period ending December 31, 2025).
How has DexCom gross profit changed year-over-year?
- DexCom (DXCM) gross profit changed +14.9% year-over-year on the latest annual filing.
What is the long-term growth rate of DexCom gross profit?
- DexCom (DXCM) gross profit compound annual growth rate is +17.0% over the most recent 5 years available.
When did DexCom gross profit hit its highest annual value?
- DexCom gross profit reached its highest annual value of $2.80B in 2025.
What was DexCom gross profit in 2024?
- DexCom (DXCM) gross profit in 2024 was $2.44B.
What was DexCom gross profit in 2025?
- DexCom (DXCM) gross profit in 2025 was $2.80B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DXCM Overview
Company profile, financial tools, and key metrics
DXCM Revenue Counter
Earns $147.83 every second. See per minute, hour, and day.
DXCM Earnings Counter
Earns $26.52 per second net profit. See per minute, hour, and day.
DXCM Economic Scale
Exceeds Suriname's GDP. Compare with world economies.
DXCM What If Invested
What if you had invested $1,000? See historical returns from any date.
DXCM How It Makes Money
Discover visual breakdown of $4.66B in revenue — where it comes from and where it goes.
DXCM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DXCM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DXCM Daily Price Character
Explosive · 49.4% historical win rate (green days). Streaks & record days.
DXCM Buybacks
1.95% TTM buyback yield. Shareholder yield & SBC comparison.
DXCM Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.